Figure 3
Figure 3. Relative risks for recurrent VTE after stopping anticoagulant therapy with ACLA vs without APLA. M-H, Mantel–Haenszel.

Relative risks for recurrent VTE after stopping anticoagulant therapy with ACLA vs without APLA. M-H, Mantel–Haenszel.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal